The designer, manufacturer and distributor of innovative medical technology for minimally invasive surgery
13-Mar-2018 – 3.93p – £30.7m – PER 15.3
Results For The 12 Months To End December 2017 – Revenues up by 44% to £8.75m (2016: £6.09m), Adjusted PBT of £1.10m (2017 reported: £0.54m, 2016: £0.28m), Adjusted EPS of 0.19 pence (2017 reported: 0.10 pence, 2016: 0.15 pence) with Net Debt at £0.73m (2016: Net Cash of £0.72m). Some Q1 headwinds (weather) but optimistic no FY impact.
Not overly convinced here and with Broker downgrades and a 6% Spread I will leave alone for now.